Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$61.71 - $77.76 $67,881 - $85,536
-1,100 Reduced 13.99%
6,763 $515,000
Q3 2023

Oct 26, 2023

BUY
$69.28 - $93.38 $544,748 - $734,246
7,863 New
7,863 $544,000
Q2 2022

Aug 10, 2022

SELL
$86.5 - $128.27 $390,374 - $578,882
-4,513 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$101.96 - $128.34 $185,873 - $233,963
1,823 Added 67.77%
4,513 $531,000
Q4 2021

Feb 03, 2022

BUY
$106.37 - $130.68 $286,135 - $351,529
2,690 New
2,690 $349,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.